Qi Li

Potential drug discovery for COVID-19 treatment targeting Cathepsin L using a deep learning-based strategy

Xi Cao, Jing Sun, Wei-Li Yang, 2022, Computational and Structural Biotechnology Journal.

Berberine is an insulin secretagogue targeting the KCNH6 potassium channel

Haixia Huang, T. Izumi, Jinkui Yang, 2021, Nature Communications.

Effect of KCNH6 on Hepatic Endoplasmic Reticulum Stress and Glucose Metabolism

Jinkui Yang, Jing-Kai Lu, Han Shen, 2020, Hormone and Metabolic Research.

KCNH6 protects pancreatic β‐cells from endoplasmic reticulum stress and apoptosis

Jinkui Yang, Jing-Kai Lu, Han Shen, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Single-cell heterogeneity analysis and CRISPR screens in MIN6 cell line reveal transcriptional regulators of insulin

Jinkui Yang, Jing-Kai Lu, Qi Li, 2021, Cell cycle.

Angiotensin‐converting enzyme 2 inhibits endoplasmic reticulum stress–associated pathway to preserve nonalcoholic fatty liver disease

Jinkui Yang, Xi Cao, Fang-yuan Yang, 2019, Diabetes/metabolism research and reviews.

An approach combining deep learning and molecule docking for drug discovery of cathepsin L

Hao Wang, Wei-Li Yang, Qi Li, 2023, Expert opinion on drug discovery.

KCNH6 channel promotes insulin exocytosis via interaction with Munc18-1 independent of electrophysiological processes

Qi Li, Jin-Kui Yang, Hao Wang, 2024, Cellular and molecular life sciences : CMLS.

Potassium voltage-gated channel subfamily H member 2 (KCNH2) is a promising target for incretin secretagogue therapies

Qi Li, Jin-Kui Yang, Hao Wang, 2024, Signal transduction and targeted therapy.